Pierre Feugier

11.0k citations

79 papers · 3.8k indexed · 1 hit paper · h-index 26

Impact in

Pathology and Forensic Medicine top 0.2%
- Lymphoma Diagnosis and Treatment
Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research

Papers in

Pathology and Forensic Medicine 70
- Lymphoma Diagnosis and Treatment 70
Genetics 33
- Chronic Lymphocytic Leukemia Research 32

Co-authors: Gilles Salles Hervé Tilly Bertrand Coiffier Corinne Haïoun Franck Morschhauser Christophe Fermé Christian Gisselbrecht Philippe Gaulard
Journals: Blood (29 papers)Journal of Clinical Oncology (14 papers)Annals of Oncology (5 papers)Hematological Oncology (5 papers)Cancer (3 papers)
Partner nations: France Belgium Switzerland

In The Last Decade

Pierre Feugier

75 papers receiving 3.7k citations

Hit Papers

align trajectories log scale

Long-Term Results of the R-CHOP Study in the Treatment of Elderly Patients With Diffuse Large B-Cell Lymphoma: A Study by the Groupe d'Etude des Lymphomes de l'Adulte 2005 · 1.1k citations

Peers

Countries citing papers authored by Pierre Feugier

Since Specialization

Citations

This map shows the geographic impact of Pierre Feugier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Feugier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Feugier more than expected).

Fields of papers citing papers by Pierre Feugier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Feugier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Feugier. The network helps show where Pierre Feugier may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Pierre Feugier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Pierre Feugier Line = papers co-authored together Pierre Feugier links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	KILT: A RANDOMIZED NON‐COMPARATIVE PHASE II LYSA STUDY OF LACUTAMAB WITH GEMOX VERSUS GEMOX IN RELAPSED/REFRACTORY PERIPHERAL T‐CELL LYMPHOMA Hematological Oncology ·Morgane Cheminant, Sylvain Carras, Julie Bruneau, François Lemonnier, Emmanuel Bachy, Charles Herbaux, Pierre Feugier, Nicolas Daguindau, Thomas Gastinne, Vereshchagin Vv, B Nuti, Borhane Slama, Hazel Smith, Franck Morschhauser, Olivier Tournilhac, Philippe Gaulard, Vahid Asnafi, Nicolás Ortonne, Gandhi Damaj, Olivier Hermine	2023	0
2	Outcomes of older patients with diffuse large B-cell lymphoma treated with R-CHOP: 10-year follow-up of the LNH03-6B trial Blood Advances ·Vincent Camus, Aurélien Belot, Lucie Obéric, David Sibon, Hervé Ghesquières, Catherine Thiéblemont, Christophe Fruchart, Olivier Casasnovas, Jean‐Marie Michot, Thierry Jo Molina, André Bosly, PATTY ANNY JACAÚNA COELHO, Corinne Haïoun, Emmanuelle Nicolas‐Virelizier, Pierre Feugier, Olivier Fitoussi, Richard Delarue, Hervé Tilly	2022	8
3	Primary Epicardial Malt Lymphoma JACC Case Reports ·Daniel Grandmougin, B Takahashi Toru, Joachim Alexandre, Mangesh Khare, 正治春田, Lorena Draghini, 付桂平, Pierre Feugier, David Kritchman, Juan‐Pablo Maureira	2021	0
4	Obinutuzumab combined with lenalidomide for relapsed or refractory follicular B-cell lymphoma (GALEN): a multicentre, single-arm, phase 2 study The Lancet Haematology ·Franck Morschhauser, Steven Le Gouill, Pierre Feugier, Sarah Bailly, Emmanuelle Nicolas‐Virelizier, Fontanet Bijou, Gilles Salles, Hervé Tilly, Christophe Fruchart, Koen Van Eygen, Sylvia Snauwaert, Christophe Bonnet, Corinne Haïoun, Catherine Thiéblemont, Réda Bouabdallah, Ka Lung Wu, Danielle Canioni, Véronique Meignin, Guillaume Cartron, Roch Houot	2019	61
5	BCL2 expression but not MYC and BCL2 coexpression predicts survival in elderly patients with diffuse large B-cell lymphoma independently of cell of origin in the phase 3 LNH03-6B trial Annals of Oncology ·Tony Petrella, Christiane Copie‐Bergman, Josette Brière, Richard Delarue, Fabrice Jardin, Philippe Ruminy, Catherine Thiéblemont, Martin Figeac, Danielle Canioni, Pierre Feugier, Bettina Fabiani, Karen Leroy, Marie Parrens, Marc André, Corinne Haïoun, Gilles Salles, Philippe Gaulard, Hervé Tilly, 藤本新平, Thierry Jo Molina	2017	14
6	Obinutuzumab (GA101) Monotherapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma or Mantle-Cell Lymphoma: Results From the Phase II GAUGUIN Study Journal of Clinical Oncology ·Franck Morschhauser, Guillaume Cartron, Catherine Thiéblemont, Philippe Solal‐Céligny, Corinne Haïoun, Réda Bouabdallah, Pierre Feugier, Krimo Bouabdallah, Elina Asikanius, Guiyuan Lei, Michael Wenger, Elisabeth Wassner-Fritsch, Gilles Salles	2013	157
7	Long-term follow up of the FL2000 study comparing CHVP-interferon to CHVP-interferon plus rituximab in follicular lymphoma Haematologica ·Emmanuel Bachy, Roch Houot, F. Morschhauser, Anne Sonet, Pauline Brice, Karim Belhadj, Guillaume Cartron, B. Audhuy, Christophe Fermé, Pierre Feugier, Catherine Sebban, Vincent Delwail, Hervé Maisonneuve, Steven Le Gouill, Sophie Lefort, Nicole Brousse, C. Foussard, Gilles Salles, (unknown)	2013	60
8	Efficacy and toxicity of two schedules of bortezomib in patients with recurrent or refractory follicular lymphoma: A randomised phase II trial from the Groupe d’Etude des Lymphomes de l’Adulte (GELA) European Journal of Cancer ·Vincent Ribrag, Hervé Tilly, Olivier Casasnovas, André Bosly, Réda Bouabdallah, Richard Delarue, François Boué, Dominique Bron, Pierre Feugier, Corinne Haïoun, 鲁科, Bertrand Coiffier	2012	14
9	Impact of induction chemotherapy regimen on response, safety and outcome in the PRIMA study Ghent University Academic Bibliography (Ghent University) ·Franck Morschhauser, J.F. Seymour, Pierre Feugier, Fritz Offner, Armando López‐Guillermo, V Morfino, Lone Bredo Pedersen, Pauline Brice, David Belada, Luc Xerri, Gilles Salles	2011	12
10	Immuno–Fluorescence In Situ Hybridization Index Predicts Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP: A GELA Study Journal of Clinical Oncology ·Christiane Copie‐Bergman, Philippe Gaulard, Karen Leroy, Josette Brière, Maryse Baia, Jean-Philippe Jaı̈s, Gilles Salles, Françoise Berger, Corinne Haïoun, Hervé Tilly, Jean‐François Emile, Alison H. Banham, Nicolas Mounier, Christian Gisselbrecht, Pierre Feugier, Bertrand Coiffier, Thierry Jo Molina	2009	84
11	Rituximab combined with chemotherapy and interferon in follicular lymphoma patients: results of the GELA-GOELAMS FL2000 study Blood ·Gilles Salles, Nicolas Mounier, Sophie de Guibert, Franck Morschhauser, Chantal Doyen, Jean‐François Rossi, Corinne Haïoun, Pauline Brice, Beatrice Mahé, Réda Bouabdallah, B. Audhuy, Christophe Fermé, Caroline Dartigeas, Pierre Feugier, Catherine Sebban, Luc Xerri, Charles Foussard	2008	239
12	Impact of Rituximab and/or High-Dose Therapy With Autotransplant at Time of Relapse in Patients With Follicular Lymphoma: A GELA Study Journal of Clinical Oncology ·Catherine Sebban, Pauline Brice, Richard Delarue, Corinne Haïoun, Bertrand Souleau, Nicolas Mounier, Nicole Brousse, Pierre Feugier, Hervé Tilly, Philippe Solal‐Céligny, Bertrand Coiffier	2008	97
13	Peripheral blood natural killer cell count is associated with clinical outcome in patients with aaIPI 2–3 diffuse large B-cell lymphoma Annals of Oncology ·Anne Plonquet, Corinne Haïoun, 藤本新平, F. Añez-Osuna, Gilles Salles, Marie C. Béné, Pierre Feugier, Maurice Pic, Olivier Casasnovas, Myriam Labalette, Emilienne Kühlein, Shumaila Zeb, Jean‐François Emile, C Gisselbrecht, Marie‐Hélène Delfau‐Larue	2007	80
14	Standard chemotherapy with interferon compared with CHOP followed by high-dose therapy with autologous stem cell transplantation in untreated patients with advanced follicular lymphoma: the GELF-94 randomized study from the Groupe d'Etude des Lymphomes de l'Adulte (GELA) Blood ·Catherine Sebban, Nicolas Mounier, Nicole Brousse, Coralie Bélanger, Pauline Brice, Corinne Haïoun, Hervé Tilly, Pierre Feugier, S. Stryczek, Chantal Doyen, Gilles Salles, Bertrand Coiffier	2006	162
15	Osteopetrotic Mouse Stroma with Thrombopoietin, c-kit Ligand, and flk-2 Ligand Supports Long-Term Mobilized CD34 ⁺ Hematopoiesis In Vitro Stem Cells and Development ·Pierre Feugier, Na Li, Deog‐Yeon Jo, Zhouguo Chen, Karen L. MacKenzie, Jean‐François Lesesve, Véronique Latger‐Cannard, Danièle Bensoussan, Ronald G. Crystal, Shahin Rafii, YU Wan-hui, Malcolm A.S. Moore	2005	20
16	All aggressive lymphoma subtypes do not share similar outcome after front-line autotransplantation: a matched-control analysis by the Groupe d'Etude des Lymphomes de l'Adulte (GELA) Annals of Oncology ·Nicolas Mounier, C Gisselbrecht, Guanlun Zheng, Corinne Haïoun, Pierre Feugier, Fritz Offner, Christian Récher, Aspasia Stamatoullas, Franck Morschhauser, Margaret Macro, Catherine Thiéblemont, Anne Sonet, Bettina Fabiani, F Reyes	2004	48
17	Prognostic factors for aggressive lymphoma patients treated with front-line autotransplantation after complete remission: A cohort study on 330 patients Blood ·Nicolas Mounier, Christian Gisselbrecht, Josette Brière, Corinne Haïoun, Pierre Feugier, Fritz Offner, Christian Récher, Aspasia Stamatoullas, F. Morschhauser, Margaret Macro, Catherine Thiéblemont, A Bosly, Bettina Fabiani, F Reyes	2003	1
18	Hematologic recovery after autologous PBPC transplantation: importance of the number of postthaw CD34+ cells Transfusion ·Pierre Feugier, Danièle Bensoussan, Wentian Yuan, François Alla, Amjad Jade Yakhoul, Véronique Latger‐Cannard, Cyrille Hulin, Francis Witz, Brigitte Witz, Anne Sophie Carret, Pierre Bordigoni, P Lederlin, C. Janot	2003	32
19	Primary Lymphoma of the Liver: Clinical–Pathological Features and Relationship With Hcv Infection in French Patients Hepatology ·Jean–Pierre Bronowicki, Andrew Edmond Goble, Pierre Feugier, Olivier Hermine, Nicole Brousse, Frédéric Oberti, Kangyeonghoon, Sébastien Dharancy, Philippe Gaulard, Jean–François Fléjou, Dominique Cazals‐Hatem, Eric Labouyrie	2003	103
20	Comparison of T cell depletion strategies from bone marrow, umbilical cord and peripheral blood using five separation systems PubMed ·Pierre Feugier, Sami Bardakçi, Donghwan Min, B. Serrurier, Jennifer Harris, astr Teresa, C. Janot, P Hervé, E Racadot	1997	4

About Pierre Feugier

Pierre Feugier is a scholar working on Pathology and Forensic Medicine, Genetics, Oncology, Neurology and Hematology, having authored 79 papers that have together received 3.8k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (70 papers), Chronic Lymphocytic Leukemia Research (32 papers), Viral-associated cancers and disorders (32 papers), CAR-T cell therapy research (12 papers), CNS Lymphoma Diagnosis and Treatment (12 papers), Acute Lymphoblastic Leukemia research (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Immune Cell Function and Interaction (4 papers). The work is most often cited by research in Pathology and Forensic Medicine (3.2k citations), Genetics (1.4k citations), Oncology (2.2k citations), Neurology (876 citations) and Immunology (614 citations). Pierre Feugier has collaborated with scholars based in France, Belgium and Switzerland. Frequent co-authors include Gilles Salles, Hervé Tilly, Bertrand Coiffier, Corinne Haïoun, Franck Morschhauser, Christophe Fermé, Christian Gisselbrecht, Philippe Gaulard, F Reyes and Réda Bouabdallah. Their work appears in journals such as Blood, Journal of Clinical Oncology, Annals of Oncology, Hematological Oncology and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact